Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Laudicella, Riccardo, Albano, Domenico, Annunziata, Salvatore, Calabrò, Diletta, Argiroffi, Giovanni, Abenavoli, Elisabetta, Linguanti, Flavia, Vento, Antonio, Bruno, Antonio, Alongi, Pierpaolo, Bauckneht, Matteo
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826849/
https://ncbi.nlm.nih.gov/pubmed/31546734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101412
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars